CASTLE BIOSCIENCES, INC. (CSTL) Total liabilities 2018–2025
CASTLE BIOSCIENCES, INC. (CSTL) total liabilities at each fiscal year-end, per SEC filings.
$107.7MFY2025 · since FY2018: $32.5M → $107.7M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $107.7M | +42.8% |
| FY2024 | $75.4M | +21.5% |
| FY2023 | $62.1M | +28.8% |
| FY2022 | $48.2M | -5.2% |
| FY2021 | $50.8M | +115.1% |
| FY2020 | $23.6M | -31.8% |
| FY2019 | $34.6M | +6.6% |
| FY2018 | $32.5M | — |
Years the filer does not tag total liabilities directly are shown as reported total assets − reported shareholders’ equity at the same fiscal year-end.
Source: SEC XBRL filings · For reference only · Not investment advice
More CSTL financial trends
CSTL RevenueCSTL Net incomeCSTL Net marginCSTL Gross profitCSTL Gross marginCSTL Operating incomeCSTL Operating marginCSTL Operating cash flowCSTL Free cash flowCSTL Capital expendituresCSTL Return on equityCSTL Stock buybacksCSTL Dividends paidCSTL Total assetsCSTL Shareholders’ equityCSTL overview →